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The cell surface adhesion molecule Mel-CAM is
highly expressed in advanced primary and metastatic
melanoma. Mel-CAM was ®rst described as an inte-
gral membrane glycoprotein of malignant melanoma
cells. The murine monoclonal antibody MAd18-5D7
recognizes an epitope of the extracellular domain of
Mel-CAM and is able to enhance Mel-CAM medi-
ated adhesion of melanoma cells in aggregation
assays. For the characterization of peptides that anti-
genically mimic surface-exposed areas of Mel-CAM
we screened a newly constructed random pVIII-28aa
bacteriophage peptide library against MAd18-5D7.
After three panning rounds a population of phages
binding to MAd18-5D7 was enriched. Peptides
expressed on the surface of these phages were then
tested for their speci®city for the antibody's antigen
binding site. DNA sequences coding for two speci®c
peptide ligands were determined. One of the
deduced amino acid sequences showed similarity to
a portion of the sequence of the third immunoglobu-
lin-like extracellular domain of Mel-CAM. Both pep-
tides blocked the interaction of MAd18-5D7 with
Mel-CAM present in a MelJuSo melanoma cell line
lysate. Phage displayed as well as synthetic peptides
inhibited in a dose-dependent manner the binding of
MAd18-5D7 to recombinant Mel-CAM in enzyme-
linked immunosorbent assay experiments. No such
inhibition was observed using a panel of other anti-
Mel-CAM antibodies. Our results clearly indicate
that these 28mer peptides are structural equivalents
of the MAd18-5D7 epitope of Mel-CAM and that
they will be useful tools for further in vitro and in vivo
studies of Mel-CAM mediated cell±cell interaction.
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M
el-CAM (also known as MUC18, MCAM, or
CD146) displays signi®cant homology to cell
adhesion molecules containing the characteristic
V-V-C2-C2-C2 immunoglobulin-like domain
structure (Holness and Simmons, 1994). The
complete coding region of Mel-CAM was originally cloned and
sequenced from a human melanoma cDNA library screened with
the monoclonal antibody MUC18 (Lehmann et al, 1989). Mel-
CAM is an integral membrane glycoprotein with a molecular mass
of 113 kDa and contains several protein kinase recognition motifs
in its cytoplasmic domain, suggesting an involvement in cell
signaling (Shih, 1999). Mel-CAM is strongly upregulated in
melanomas compared to benign lesions and is expressed by more
than 80% of metastatic lesions (Kraus et al, 1997). It is also found on
normal endothelium among several other tissue types (Shih, 1999),
e.g., on activated T cells (Pickl et al, 1997), smooth muscles (Shih et
al, 1994), and vascular endothelial cells (Bardin et al, 1996; St Croix
et al, 2000). Its function for these cells is unclear. For melanoma
cells recent data suggest that Mel-CAM is involved in cell±cell
adhesion (Satyamoorthy et al, 2001). The expression of Mel-CAM
on melanoma cells correlates with an invasive phenotype indicating
its use as a cell surface marker of metastasis formation and tumor
progression (Xie et al, 1997). Mel-CAM has been shown to be
involved in tumor±endothelial cell interaction that might be part of
the extravasation process of tumor cells (Johnson et al, 1997; Shih et
al, 1997). To date the ligand mediating heterophilic aggregation
remains unidenti®ed (Shih et al, 1997). It has been reported that
activation of Mel-CAM leads to tyrosine phosphorylation of
p125FAK and of paxillin and is associated with p59fyn (Anfosso et al,
1998).
The use of bacteriophage display peptide libraries greatly
facilitates identifying peptide ligand-binding sites for proteins of
interest that are dif®cult to identify by conventional techniques.
Smith et al pioneered bacteriophage library construction in which
vectors are constructed for expression of random peptides fused to
phage coat proteins, e.g. pIII or pVIII of ®lamentous phage (Smith,
1985; reviewed by Zwick et al, 1998). Peptide sequences that bind
to a wide range of ligands such as monoclonal antibodies, receptors,
and carbohydrate moieties have been successfully identi®ed (Moe et
al, 1999; Ruoslahti, 2000). We applied bacteriophage display
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technology to de®ne structural equivalents (mimotopes) of the cell
adhesion molecule Mel-CAM that mimic its epitope of MAd18-
5D7.
MATERIALS AND METHODS
Antibodies and phage display peptide library The pVIII-28aa phage
display peptide library is composed of random 28 amino acid residues,
displayed on ®lamentous phage as fusion to the NH2-terminus of the
major coat protein pVIII. The library has been generated essentially as
described previously, by cloning an oligonucleotide containing 28
randomized codons (27 NNS and one NNG triplet) in the pC89
phagemid vector (Felici et al, 1991). Library complexity as derived from
the number of individual clones obtained upon bacterial transformation
was about 1 3 108.
The anti-Mel-CAM monoclonal antibodies MUC BA18.3 and
MUC18 were a gift of J. P. Johnson (Institute of Immunology,
University of Munich, Munich, Germany) and are described elsewhere
(Lehmann et al, 1987; 1989). MAd18-5D7 is a mouse IgM monoclonal
antibody (MoAb) and was selected on the basis of its functional activity
of enhancing Mel-CAM mediated adhesion in aggregation assays
(J. P. Johnson, Institute of Immunology, University of Munich, Munich,
unpublished results). The MoAbs MUC18 and MUC BA18.3 are mouse
IgGs. MUC BA18.3 is directed against the cytoplasmic region of Mel-
CAM (Lehmann et al, 1989). MUC18 recognizes an epitope of the
extracellular portion of the Mel-CAM molecule (Lehmann et al, 1987).
For isotype control the mouse IgM MoAb clones TEPC 183 and
MOPC 104E as well as the human IgM MoAb I8260 were purchased
from Sigma-Aldrich (St. Louis, MO).
Cell lines and recombinant Mel-CAM The human melanoma cell
line MelJuSo (Lehmann et al, 1987) that expresses high levels of Mel-
CAM and the melanoma cell line MD3a (Versteeg et al, 1989) with no
detectable expression of Mel-CAM were cultured in RPMI 1640
medium supplemented with 10% fetal bovine serum and antibiotics
(Gibco, Invitrogen, Carlsbad, CA). The recombinant extracellular Mel-
CAM domain was a gift of M. Herlyn (The Wistar Institute,
Philadelphia, PA) and is described elsewhere (Shih et al, 1997).
Selection of speci®c phages from the pVIII-28aa phage display
peptide library For each round of selection polystyrene tubes (Nunc,
Naperville, IL) were coated overnight at 4°C with 10 mg of the murine
MoAb MAd18-5D7 per ml coating buffer (50 mM NaHCO3, pH 9.4).
Tubes were then blocked with blocking buffer (5 mg per ml dialyzed
bovine serum albumin and 0.02% NaN3 in 0.1 M NaHCO3, pH 9.6)
and washed extensively with phosphate-buffered saline (PBS), 0.1%
Tween 20. Incubation was performed with 1012 phage previously
preabsorbed on MoAbs TEPC183 and MOPC 104E at room
temperature for 1 h. After washing with PBS/0.1% Tween 20, bound
phages were eluted with glycin±HCl, pH 2.2, and neutralized with 1 M
Tris±HCl, pH 9.1. Eluted phages were ampli®ed by infecting Escherichia
coli TG1 at an optical density at 600nm of 1.5 and puri®ed with a 20%
PEG/2.5 M NaCl precipitation. Two further rounds of selection where
performed against the antibody MAd18-5D7. After three rounds of
selection colony screening was performed (Felici et al, 1991). Phages
were puri®ed from single colonies and tested for their reactivity with
MAd18-5D7 by phage enzyme-linked immunosorbent assay (ELISA).
Third round phage pool analysis The pool of phages from the third
selection round was analyzed by sequencing single phage clones.
Phagemid DNA was puri®ed from overnight cultures of single phage
clones. DNA sequencing was performed by the Sanger dideoxy method
using a pVIII speci®c ¯uorescent labeled primer (Leitner et al, 1998) and
analyzed by a LI-COR DNA Sequencer 4000 L (LI-COR, Lincoln,
NE).
Phage ELISA Ninety-six well microtiter plates (Maxisorp, Nunc)
were coated with 2 mg anti-pIII antibody (Dente et al, 1994) per ml
coating buffer overnight at 4°C. Plates were blocked (5% skim milk and
0.05% Tween 20 in PBS, pH 7.3) for 2 h at room temperature and
washed (0.05% Tween 20 in PBS, pH 7.3). Puri®ed phages were diluted
in blocking buffer and plates were incubated with the dilutions for 3 h at
room temperature. After further washing and incubating with 1 mg each
MAd18-5D7, MUC BA18.3, MUC18, and 1 mg of an equimolar mix of
TEPC 183 and MOPC 104E per ml blocking buffer, bound IgM or IgG
was detected using AP-conjugated antimouse IgM (m-speci®c) or IgG
(m-speci®c) (Sigma) followed by addition of p-nitrophenylphosphate
(Sigma). The absorbance was measured at 405 nm.
Synthesis of peptides The peptides GRALPGTAEWTSYPGWTSR-
LKNLEPAVG (mimotope 1) and RVKHMLVGASSRVPGFFSSLPGF-
QGPFT (mimotope 2) and an unrelated peptide (ch3) were synthesized
by piCHEM (Graz, Austria). The purity of the peptides was greater than
95% as assessed by high performance liquid chromatography.
ELISA inhibition assay Ninety-six well microtiter plates (Maxisorp,
Nunc) were coated overnight at 4°C with 1 mg recombinant Mel-CAM
per ml coating buffer (50 mM NaHCO3, pH 9.6). One microgram
MAd18-5D7 was preincubated with varying concentrations (103, 106,
and 109) of puri®ed phages overnight at 4°C and added to the blocked
microtiter plates. Bound IgM was detected using AP-conjugated
antimouse IgM (m-speci®c) (Sigma) followed by addition of
p-nitrophenylphosphate (Sigma). The absorbance was measured at
405 nm. As controls, wild-type phage wt pc89, phages displaying
unrelated peptides not speci®c for MAd18-5D7, and the MoAbs TEPC
183, MOPC 104E, and I8260 (Sigma) as isotype controls were used in
the above-mentioned concentrations. In an additional ELISA inhibition
assay 0.5 mg MAd18-5D7 was preincubated with varying concentrations
(1, 10, 100, and 500 mg) of synthetic peptides and then transferred to an
ELISA plate coated with recombinant Mel-CAM. The assay was
continued as described above.
Immunoblot and inhibition assay For Western blotting, MelJuSo
and MD3a cells were lyzed in lysis buffer [50 mM Tris, 150 mM NaCl,
1% Nonidet P-40, 0.5% deoxycholic acid, 0.1% sodium dodecyl sulfate
(SDS)] to obtain protein lysates for immunoblotting experiments and
adjusted to a protein concentration of 500 mg per ml. Proteins of
MelJuSo and MD3a protein lysates were separated on an 8%
polyacrylamide gel and transferred onto a nitrocellulose membrane
(Schleicher and Schuell, Keene, NH). Five micrograms of recombinant
Mel-CAM were electrophoresed on an 8% polyacrylamide gel and
transferred onto a nitrocellulose membrane (Schleicher and Schuell).
Antibodies MAd18-5D7 and MUC BA18.3 were preincubated with
5 3 109 puri®ed phages overnight at 4°C and added to the blocked
nitrocellulose membrane. Wild-type phage wt pc89 in the same
concentration as the phages displaying peptides was used as control.
Bound antibodies were visualized using an AP-conjugated antimouse
IgM (m-speci®c) (Sigma) or an AP-conjugated antimouse IgG
(g-speci®c), respectively, followed by equilibration in AP buffer (0.1 M
Tris base, pH 9.5, 0.1 M NaCl, 1 mM MgCl2) and development with
nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate-p-
toluidine.
Phage proteins were electrophoresed in 15% SDS polyacrylamide gel
electrophoresis (PAGE) and transferred to nitrocellulose membranes.
Blocked membranes were incubated with the MoAbs MAd18-5D7,
MUC18, MUC BA18.3, TEPC 183, MOPC 104E, and I8260 and their
respective secondary antibodies and developed as mentioned above.
RESULTS
Identi®cation of MAd18-5D7 speci®c ligands We screened a
linear pVIII-28mer phage peptide library to identify ligands that are
able to bind speci®cally to the antigen recognition site of the MoAb
MAd18-5D7. Three rounds of biopanning using the MoAb
MAd18-5D7 as a target were performed. Throughout these
rounds the phage pool was enriched to 9 3 1011 phages per ml
elution buffer. In colony screening 53 single clones reacted with the
MoAb MAd18-5D7. A phage ELISA was performed to test the
clones' speci®city for MAd18-5D7. Phages that produced an
OD405 greater than the mean 6 3SD of wt pc89 phage were
considered to be speci®c for the antibody. Ten clones produced
such an OD greater than the mean 6 3SD of wild-type phage wt
pc89 (OD 6 SD = 0.064 6 0.004). These clones were regarded
as speci®c for the antibody and subjected to DNA sequencing (data
not shown).
Sequence analysis Single stranded DNA of the 10 phage clones
that bound speci®cally to the MoAb MAd18-5D7 was puri®ed and
the inserts coding for the mimotopes were sequenced. Two
different sequences were obtained. Eight phage clones displayed
mimotope 1, and two clones displayed mimotope 2. By linear
alignment using the BLAST search algorithm it was possible to
align the sequence of mimotope 1 to the sequence of Mel-CAM
between amino acid positions 307±310 (LEPA). For mimotope 2
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no linear alignment to the sequence of Mel-CAM could be
observed. The deduced amino acid sequences are listed in Fig 1.
Phage ELISA A phage ELISA to con®rm the speci®city of the
two selected mimotopes for the MoAb MAd18-5D7 was
performed. Therefore, the two mimotopes were tested for
binding to the MoAb MAd18-5D7 as well as to the control
antibodies MUC BA18.3, MUC18, TEPC 183, and MOPC 104E.
Both mimotopes only bound to the selecting antibody MAd18-
5D7 (Fig 2).
Immunoblot Recombinant Mel-CAM and proteins of a
MelJuSo lysate were electrophoresed and blotted onto
nitrocellulose membrane. Strips were incubated with MAd18-
5D7 or MUC BA18.3. A single band was visible at approximately
113 kDa for natural Mel-CAM with MAd18-5D7 or MUC
BA18.3 (Fig 3a). MAd18-5D7 reacted with the recombinant
extracellular domain of Mel-CAM (Fig 3b), whereas no band was
observed in a lysate of the Mel-CAM negative cell line MD3a (data
not shown).
Immunoblot inhibition To test phage displayed mimotopes 1
and 2 for their ability to inhibit the binding of MoAb MAd18-5D7
to Mel-CAM, the antibody was preincubated with 5 3 109 phages
displaying mimotope 1 or 2 peptides, respectively, and then used to
probe a MelJuSo lysate blotted to nitrocellulose strips. Both
mimotopes were able to abolish the binding of MAd18-5D7 to
Mel-CAM in the MelJuSo cell line lysate as well as to recombinant
Mel-CAM (Fig 3a, b). No inhibition was detected when
preincubating MAd18-5D7 with the unrelated phage displayed
peptide ch3, obtained by panning the mouse MoAb BIP1 (Jarolim
et al, 1989) with the 28mer library. No inhibition was observed
when MAd18-5D7 was preincubated with wild-type phage wt
pc89 (Fig 3a, b). No inhibition was observed when the MoAb
MUC BA18.3 was preincubated with the phages displaying the
peptides or when the preincubation was performed with wild-type
phage wt pc89 (Fig 3a). Immunoblots of SDS-PAGE separated
phage proteins were used to demonstrate the speci®city of binding.
Speci®c IgM binding phages displaying peptide mimotopes 1 and 2
were subjected to 15% SDS-PAGE, blotted onto nitrocellulose,
and incubated with either MAd18-5D7 or TEPC 183, MOPC
104E, I8260, and MUC18. A signal occurred for the phage proteins
only in the lane containing MoAb MAd18-5D7 but not with the
other tested IgM MoAbs or IgG MoAb. No reactivity was observed
with any of the irrelevant phage clones or with wild-type phage wt
pc89 (data not shown).
ELISA inhibition assay In an ELISA assay, phage displayed
mimotopes 1 and 2 were tested for their ability to inhibit the
binding of MAd18-5D7 antibody to recombinant Mel-CAM. Both
mimotopes inhibited the binding of MAd18-5D7 to recombinant
Mel-CAM in ELISA in a dose-dependent manner (Fig 4a). An
ELISA inhibition assay was performed with synthetic peptides to
exclude that phage displayed peptides were constrained by the
structural context of the bacteriophage surface. The result is shown
in Fig 4(b) and demonstrates that inhibition occurs in a dose-
dependent manner with the synthetic mimotopes 1 and 2 but not
with the unrelated peptide ch3. Mimotope 1 inhibited 89% and
mimotope 2 inhibited 54% of the binding of MAd18-5D7 to
recombinant Mel-CAM. The unrelated peptide ch3 did not
in¯uence the binding characteristics of MAd-5D7. These data
clearly show that the synthetic peptides possess an inhibitory
capacity comparable to the phage displayed mimotopes.
DISCUSSION
In melanoma cells and in more than 80% of metastatic lesions the
cell surface adhesion molecule Mel-CAM is highly expressed
(Kraus et al, 1997). The murine MoAb MAd18-5D7 directed
against Mel-CAM is able to enhance Mel-CAM mediated adhesion
of melanoma cells in aggregation assays (J. P. Johnson, Institute of
Immunology, University of Munich, Munich, Germany, unpub-
lished results). Our aim was to select low molecular weight
structural equivalents (mimotopes) of the epitope of Mel-CAM that
is recognized by MAd18-5D7 for future use as reagents to study the
involvement of Mel-CAM in cell adhesion. Phage display peptide
libraries are routinely used to characterize binding sites of
antibodies and thereby de®ne the epitope of the original antigen
(Zwick et al, 1998; Moe et al, 1999). Commonly used phage
libraries display peptides of up to 15 amino acid residues with
random structure.
In this study we constructed and used for the ®rst time a linear
28mer phage display peptide library to select mimotopes for the
murine IgM MoAb MAd18-5D7. In the past several authors have
already demonstrated that mimotopes can be obtained from peptide
phage libraries and that these sequences can bind antibodies raised
against native structures (Cwirla et al, 1990; Zwick et al, 1998). It
has also been shown that mimotopes can mimic carbohydrate
structures and oligonucleotide structures (Gaynor et al, 1997; Moe
et al, 1999).
A random peptide library will contain a larger amount of
diversity information for an increase in the length of the displayed
peptide compared to shorter ones deriving from the same number
of clones. At the same time the average number of copies of
recombinant pVIII molecules displayed per phage particle will
become smaller (Iannolo et al, 1995; Malik et al, 1996). The 28mer
size of our random peptide library corresponds to the size of a small
protein domain like that of a 26 amino acid Cys2His2 consensus
``zinc-®nger'' motif used to produce a conformationally homo-
geneous combinatorial peptide library (Bianchi et al, 1995). We
have no direct information on the structure of the selected 28mers.
Figure 1. Insert sequences of phages displaying mimotopes for
MoAb MAd18-5D7. Frequency denotes the percentage of phage clones
sequenced with identical inserts.
Figure 2. Phage ELISA to determine the reactivity of phage
displayed mimotopes 1 and 2 and wild-type phage wt pc89 with
the antibody MAd18-5D7. Microtiter 96-well plates were coated with
anti-pIII antibody, and 5 3 1010 phages were added to each well,
followed by MoAb MAd18-5D7, MUC BA18.3, MUC18, and an
equimolar mix of two unrelated IgM antibodies (TEPC 183, MOPC
104E). Binding results are shown as A405 (mean and SD).
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In general, the role of residues ¯anking a conserved core sequence
may be to provide minor, less speci®c interactions with the target
or to constrain the conformation of the core motif (Katz, 1997).
We preincubated our 28mer phage display peptide library on
puri®ed mouse IgM to exclude peptides that bind to the constant
region of an IgM molecule. The selection of ligand-binding phage
particles was achieved by three rounds of panning of the library
against the antibody MAd18-5D7 bound to a solid phase. The pool
of phages from the third selection round was analyzed by
sequencing of single phage clones. Two clones bearing peptide
sequences that appeared more than once were selected for a more
detailed study of their binding characteristics (Fig 2). Both clones
that bound to MAd18-5D7 did not react with several IgM
antibodies of various origins. This clearly demonstrated the absence
of cross-reactivity of the selected phage clones. Furthermore, the
binding of MAd18-5D7 to recombinant Mel-CAM could be
inhibited by both phage displayed peptides (Figs 3b, 4a). This
inhibition was also shown with synthetic peptides to exclude that
the conformations of the phage displayed peptides were constrained
by the structural context of the bacteriophage surface (Fig 4b).
These results clearly indicate that the synthetic peptides adopted a
conformation in solution that was comparable to the one on the
phage surface. MoAb MUC BA18.3 also directed to Mel-CAM
could not be inhibited by either of the two mimotopes (Fig 3a).
This proves that the mimotopes are genuine antigenic mimics of
the MAd18-5D7 epitope on Mel-CAM.
By linear alignment using the BLAST algorithm it was possible
to align the peptide sequence of the mimotope 1 to the sequence of
Mel-CAM between amino acid positions 307±310 (LEPA) of the
extracellular domain of Mel-CAM. These amino acid residues
contribute to the third immunoglobulin-like domain of Mel-
CAM. For mimotope 2 no linear alignment to the sequence of
Mel-CAM could be found. This and the results of the inhibition
studies illustrate that sequence homology between a mimotope and
the original epitope is not obligatory for the formation of an
equivalent structure.
Mimotopes can be used in many ways as is well documented in
the literature. Phage clones isolated from peptide libraries are in
Figure 3. Immunoblot assay showing the ability of phage
displayed mimotopes 1 and 2 to inhibit the binding of MoAb
MAd18-5D7 to (a) natural and (b) recombinant Mel-CAM. (a)
MelJuSo protein lysate or (b) 5 mg Mel-CAM were separated by 8% SDS-
PAGE and proteins were transferred to a nitrocellulose membrane. Strips
were incubated with MoAb MAd18-5D7 (lane 1), MoAb MAd18-5D7
preincubated with phage displayed mimotope 1 (lane 2), mimotope 2
(lane 3), or wild-type phage wt pc89 (lane 4), and for (a) with MoAb
MUC BA18.3 (lane 5), and MoAb MUC BA18.3 preincubated with
phage displayed mimotope 1 (lane 6) or mimotope 2 (lane 7). B, buffer
control; C, isotype control; arrow in (b) indicates position of
recombinant Mel-CAM.
Figure 4. ELISA assays to determine peptide inhibition of MoAb
MAd18-5D7 binding to recombinant Mel-CAM. (a) Inhibition of
MoAb MAd18-5D7 binding to recombinant Mel-CAM by phage
displayed mimotopes. MAd18-5D7 was preincubated with increasing
concentrations of speci®c phage displayed peptides (mimotope 1 and 2)
or wild-type phage wt pc89, and incubated with recombinant Mel-CAM
coated to a microtiter plate. Binding of MAd18-5D7 to recombinant
Mel-CAM was measured using an AP-conjugated antimouse IgM (m-
speci®c). Binding results are shown as A405 (mean and SD). (b)
Synthetic peptide inhibition of MoAb MAd18-5D7 binding to
recombinant Mel-CAM. MAd18-5D7 was preincubated with increasing
concentrations of synthetic mimotopes 1 and 2 or unrelated synthetic
peptide ch3, and incubated with recombinant Mel-CAM coated to a
microtiter plate. Binding of MAd18-5D7 to recombinant Mel-CAM was
measured using an AP-conjugated antimouse IgM (m-speci®c). Binding
results are shown as A405 (mean and SD).
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some cases able to induce an effectively speci®c humoral immune
response in vivo directed against the epitope recognized by the
MoAb used for af®nity selection (Meola et al, 1995). Furthermore
protective immune response by mimotope immunization has been
shown for viral antigens, pollen allergens, and tumor antigens
(Zucchelli et al, 2001; Jensen-Jarolim et al, 1998; Popkov et al,
2000).
The quantitative and qualitative changes between normal and
malignant tumor cells are often shown in different expression of
adhesion molecules. In malignant melanoma Mel-CAM expression
gradually increases and is on the highest level in metastatic
melanoma (Shih et al, 1994). Whereas human melanoma cells show
a Mel-CAM-dependent adhesion to endothelial cells, it remains
unclear if this requires Mel-CAM or Mel-CAM ligand expression
(Shih et al, 1997). Genetic suppressor elements speci®c for Mel-
CAM inhibit melanoma growth and invasion through loss of gap
junction communication in a three-dimensional tissue reconstruct,
suggesting that Mel-CAM affects connexin expression or acts per se
as glue between cells and facilitates gap junction formation
(Satyamoorthy et al, 2001). Another function that can be attributed
to Mel-CAM is cation-independent homotypic adhesion of
melanoma cells mediated through an unidenti®ed ligand, which
is not Mel-CAM (Johnson et al, 1997; Shih et al, 1997).
In summary, our data suggest that the described synthetic
mimotopes can replace phage displayed mimotopes as the more
useful tools for the careful study of the interaction of the MoAb
MAd18-5D7 with melanoma cells. Ultimately, it may become
possible to study the ability of the mimotopes to inhibit the
interaction of a putative ligand with Mel-CAM, or the ability to
interfere with the aggregation of melanoma cells. Such experiments
should clarify whether the MAd18-5D7 epitope on Mel-CAM is
involved in increased cell aggregation of melanoma cells and the
formation of metastases.
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